Genetic Super Soldier Blueprint
Budget: £750 – £1,500 GBP
I’m developing a grounded, science-based plan to create enhanced humans through targeted genetic modifications that boost raw physical performance—strength, speed, endurance, and recovery. The goal at this stage is a detailed, actionable blueprint I can take forward for funding and phased lab work.
Key tasks and deliverables:
• Literature review summarising state-of-the-art CRISPR/Cas and related editing techniques relevant to myostatin inhibition, mitochondrial biogenesis, and muscle fiber hypertrophy.
• Selection and justification of gene targets, delivery vectors, and off-target risk assessments.
• Step-by-step lab protocol draft (in vitro through in vivo pre-clinical), including required equipment, reagents, and estimated timelines. .
• Performance-enhancement metrics and a proposed testing framework to quantify strength, VO₂ max, and recovery gains.
• High-level project roadmap showing milestones, costs, and decision gates for a twelve-month pilot programme.
A strong background in molecular biology, gene therapy, or human performance science is essential. Familiarity with CRISPR, AAV/LNP delivery platforms, and current regulatory guidance will help you hit the ground running. Clear, concise documentation—preferably in a well-structured report with citations—will be the primary success metric.
Key tasks and deliverables:
• Literature review summarising state-of-the-art CRISPR/Cas and related editing techniques relevant to myostatin inhibition, mitochondrial biogenesis, and muscle fiber hypertrophy.
• Selection and justification of gene targets, delivery vectors, and off-target risk assessments.
• Step-by-step lab protocol draft (in vitro through in vivo pre-clinical), including required equipment, reagents, and estimated timelines. .
• Performance-enhancement metrics and a proposed testing framework to quantify strength, VO₂ max, and recovery gains.
• High-level project roadmap showing milestones, costs, and decision gates for a twelve-month pilot programme.
A strong background in molecular biology, gene therapy, or human performance science is essential. Familiarity with CRISPR, AAV/LNP delivery platforms, and current regulatory guidance will help you hit the ground running. Clear, concise documentation—preferably in a well-structured report with citations—will be the primary success metric.